These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Degradation of recombinant hirudin-2 in nasal mucosa of rabbits in vitro].
    Author: Zhang YJ, Wu JM, Zhang Q, Chen MX, Sun WJ.
    Journal: Yao Xue Xue Bao; 2006 Nov; 41(11):1099-103. PubMed ID: 17262955.
    Abstract:
    AIM: To investigate the degradation of recombinant hirudin-2 (rHV2) in nasal mucosa of rabbit. METHODS: The specific and accurate HPLC method was developed for analyzing rHV2; The degrading ratios of rHV2 at different concentrations and at pH conditions in rabbit nasal mucosa homogenate were determined; The results in nasal mucosa homogenate were compared with that in small intestinal mucosa homogenate of rabbits. The stability of rHV2 in the enzyme extract of nasal mucosa surface and the effect of proteolysis inhibitor bacitracin on the degradation of rHV2 in nasal mucosa homogenate were also estimated. RESULTS: The degradation of rHV2 in rabbit nasal mucosa homogenate showed concentration- and pH-dependence; rHV2 in nasal mucosa homogenate was more stable than that in intestinal mucosa homogenate. Also rHV2 was more stable in the enzyme extracts of nasal serosal surface than that of mucosa surface. Addition of bacitracin was able to inhibit the degradation to some degree. CONCLUSION: Comparing with oral administration, rHV2 nasal delivery was a more tolerant route.
    [Abstract] [Full Text] [Related] [New Search]